Back to Global NewsPublished: 23 Feb 2026Download AppJoin TelegramuniQure's Q4 Earnings Could Signal a Gene‑Therapy Boom—or a Hidden Risk#uniQure#gene therapy#biotech earnings#investor outlook#healthcare stocksDownload AppJoin CommunityShare Article